What was the "rumour" deal for HER-Vaxx??? I recall someone posting it was $1 which explain the pps rising to 60c but $6B for a product which hasn't completed Ph2 is way too excessive to me despite the market for Chemotherapy, maybe had HER-Vaxx completed Ph3. Azer-Cel is targeting the blood cancer market so how is this the "same" as solid cancer market, LC mentioned there is a synergy between Azer-Cel and CF33 which was why IMU acquired the IP didn't she????
What was the "rumour" deal for HER-Vaxx??? I recall someone...
-
- There are more pages in this discussion • 1,241 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.002(3.57%) |
Mkt cap ! $401.6M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $1.182M | 21.47M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 3441484 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 574188 | 6 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |